Antiviral diseases

November 6, 2017

Antiviral therapy for HIV virus: Nafamostat Mesilate increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 6/November/2017, 11.18 pm

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Antiviral therapy for HIV virus: Nafamostat Mesilate increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation […]
November 5, 2017

Antiviral therapy against Neuroinvasive West Nile virus: Nafamostat Mesilate (NM) increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 11/November/2017, 10.41 pm

Introduction: What they say A study from the Department of Immunology, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of […]
November 3, 2017

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Artemisinin and Suramin inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1,  respiratory syncytical ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 3/November/2017,  8.13 am

Introduction: What they say:  A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA […]
November 3, 2017

Antiviral therapy for Neuroinvasive West Nile virus:  Ribavirin/Tribavirin, an antiviral drug used in the treatment of RSV infection, hepatitis C, and viral hemorrhagic fever, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 3/November/2017, 7.31 am

Introduction: What they say A study from the Department of Immunology, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University […]